Wendell F. Rosse

Wendell F. Rosse's AcademicInfluence.com Rankings

Wendell F. Rosse

Philosophy

#6479

World Rank

#9521

Historical Rank

Logic

#3635

World Rank

#4826

Historical Rank

philosophy Degrees

Download Badge

Philosophy

Why Is Wendell F. Rosse Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Wendell F. Rosse's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Mortality in sickle cell disease. Life expectancy and risk factors for early death. (1994) (3028)
Pain in sickle cell disease. Rates and risk factors. (1991) (1449)
Diagnosis and management of paroxysmal nocturnal hemoglobinuria. (2005) (705)
Quantitative determination of antibody in idiopathic thrombocytopenic purpura. Correlation of serum and platelet-bound antibody with clinical response. (1975) (445)
The natural history of paroxysmal nocturnal hemoglobinuria. (1997) (328)
Guidelines for the diagnosis and monitoring of paroxysmal nocturnal hemoglobinuria and related disorders by flow cytometry (2010) (310)
Transfusion and alloimmunization in sickle cell disease. The Cooperative Study of Sickle Cell Disease (1990) (295)
Immune lysis of normal human and paroxysmal nocturnal hemoglobinuria (PNH) red blood cells. I. The sensitivity of PNH red cells to lysis by complement and specific antibody. (1966) (283)
Clinical Course and Flow Cytometric Analysis of Paroxysmal Nocturnal Hemoglobinuria in the United States and Japan (2004) (224)
The use of monoclonal antibodies and flow cytometry in the diagnosis of paroxysmal nocturnal hemoglobinuria. (1996) (217)
Pulmonary hypertension and nitric oxide depletion in sickle cell disease. (2010) (206)
Complement-induced vesiculation and exposure of membrane prothrombinase sites in platelets of paroxysmal nocturnal hemoglobinuria. (1993) (199)
The Role of Cholesterol and Glycosylphosphatidylinositol-anchored Proteins of Erythrocyte Rafts in Regulating Raft Protein Content and Malarial Infection* (2001) (197)
Transfusion and alloimmunization in sickle cell disease. The Cooperative Study of Sickle Cell Disease. (1990) (184)
Baseline characteristics and disease burden in patients in the International Paroxysmal Nocturnal Hemoglobinuria Registry (2014) (177)
Long‐term effect of the complement inhibitor eculizumab on kidney function in patients with paroxysmal nocturnal hemoglobinuria (2010) (173)
Paroxysmal Nocturnal Hemoglobinuria as a Molecular Disease (1997) (167)
Immune hemolytic anemias. (1971) (165)
The cooperative study of sickle cell disease: review of study design and objectives. (1982) (151)
Splenectomy for Primary and Recurrent Immune Thrombocytopenic Purpura (ITP): Current Criteria for Patient Selection and Results (1987) (151)
Paroxysmal nocturnal hemoglobinuria with onset in childhood and adolescence. (1991) (146)
The molecular basis of paroxysmal nocturnal hemoglobinuria. (1995) (146)
Acquired DNA mutations associated with in vivo hydroxyurea exposure. (2000) (135)
Phosphatidylinositol-linked proteins and paroxysmal nocturnal hemoglobinuria. (1990) (117)
Quantitative immunology of immune hemolytic anemia: II. The relationship of cell-bound antibody to hemolysis and the effect of treatment. (1971) (107)
Immune thrombocytopenia in lymphoproliferative diseases. (1979) (106)
Immune-mediated hemolytic anemia. (2004) (102)
PLATELET ANTIBODY IN AUTOIMMUNE THROMBOCYTOPENIA (1975) (101)
Variations in the Red Cells in Paroxysmal Nocturnal Haemoglobinuria (1973) (101)
Phosphatidylinositol-linked proteins and paroxysmal nocturnal hemoglobinuria (1990) (97)
The impact of current staging procedures in assessing disease extent of prostatic adenocarcinoma. (1979) (95)
Mutations within the Piga gene in patients with paroxysmal nocturnal hemoglobinuria. (1994) (93)
Platelet-bound complement (C3) in immune thrombocytopenia. (1977) (92)
The origin of ABH antigens on human platelets. (1985) (91)
IMMUNE LYSIS OF NORMAL HUMAN AND PAROXYSMAL NOCTURNAL HEMOGLOBINURIA (PNH) RED BLOOD CELLS (1966) (88)
Defective glycosylphosphatidylinositol anchor synthesis in paroxysmal nocturnal hemoglobinuria granulocytes. (1992) (82)
The use of in vitro technics to study drug-induced pancytopenia. (1979) (75)
Morphologic changes in the membranes of red blood cells undergoing hemolysis. (1966) (75)
The structure of the urokinase-type plasminogen activator receptor gene. (1994) (74)
New insights into paroxysmal nocturnal hemoglobinuria (2001) (74)
New Views of Sickle Cell Disease Pathophysiology and Treatment. (2000) (73)
Immune lysis of normal human and paroxysmal nocturnal hemoglobinuria (PNH) red blood cells. II. The role of complement components in the increased sensitivity of PNH red cells to immune lysis. (1966) (72)
Mechanisms of immune lysis of red blood cells in vitro. I. Paroxysmal nocturnal hemoglobinuria cells. (1973) (71)
Platelet survival and turnover: Important factors in predicting response to splenectomy in immune thrombocytopenic purpura (1989) (70)
STUDIES ON THE METABOLISM OF THE SERUM PROTEINS AND LIPIDS IN A PATIENT WITH ANALBUMINEMIA. (1964) (69)
Regulation of the activity of platelet-bound C3 convertase of the alternative pathway of complement by platelet factor H. (1987) (69)
The erythrocytes in paroxysmal nocturnal haemoglobinuria of intermediate sensitivity to complement lysis (1991) (67)
Mechanism of complement-mediated activation of human blood platelets in vitro: comparison of normal and paroxysmal nocturnal hemoglobinuria platelets. (1977) (67)
Interactions of the platelets in paroxysmal nocturnal hemoglobinuria with complement. Relationship to defects in the regulation of complement and to platelet survival in vivo. (1987) (66)
Fixation of the first component of complement (C'la) by human antibodies. (1968) (66)
Familial cold urticaria. A generalized reaction involving leukocytosis. (1969) (65)
Fragment D-dimer levels: an objective marker of vaso-occlusive crisis and other complications of sickle cell disease. (1986) (62)
The variability of hemolysis in the cold agglutinin syndrome. (1980) (61)
Production of IgM hexamers by normal and autoimmune B cells: implications for the physiologic role of hexameric IgM. (1998) (61)
Paroxysmal nocturnal hemoglobinuria. (1992) (61)
Mechanisms of immune lysis of the red cells in hereditary erythroblastic multinuclearity with a positive acidified serum test and paroxysmal nocturnal hemoglobinuria. (1974) (61)
The life-span of complement-sensitive and -insensitive red cells in paroxysmal nocturnal hemoglobinuria. (1971) (59)
Renal cysts, erythropoietin and polycythemia. (1963) (59)
Structure of the CD59-encoding gene: further evidence of a relationship to murine lymphocyte antigen Ly-6 protein. (1992) (58)
Immunophenotypic analysis of reticulocytes in paroxysmal nocturnal hemoglobinuria. (1995) (55)
Treatment of paroxysmal nocturnal hemoglobinuria (1982) (54)
Acute myeloblastic leukemia in paroxysmal nocturnal hemoglobinuria. Evidence of evolution from the abnormal paroxysmal nocturnal hemoglobinuria clone. (1987) (52)
Erythrocyte acetylcholinesterase deficiency in paroxysmal nocturnal hemoglobinuria (PNH). A comparison of the complement-sensitive and insensitive populations. (1969) (52)
Clinical Manifestations of Paroxysmal Nocturnal Hemoglobinuria: Present State and Future Problems (2003) (51)
The spleen as a filter. (1987) (50)
The response of human neutrophils to a chemotactic tripeptide (N-formyl-methionyl-leucyl-phenylalanine) studied by microcinematography. (1984) (49)
Erythrocyte antigens on human platelets. Absence of Rh, Duffy, Kell, Kidd, and Lutheran antigens (1984) (49)
Potassium permeability in -thalassemia minor red blood cells. (1972) (49)
Resolution of Budd‐Chiari syndrome following bone marrow transplantation for paroxysmal nocturnal haemoglobinuria (1996) (49)
The acetylcholinesterase defect in paroxysmal nocturnal hemoglobinuria: evidence that the enzyme is absent from the cell membrane (1985) (48)
Paroxysmal nocturnal hemoglobinuria: the biochemical defects and the clinical syndrome. (1989) (47)
Reactions of immunoglobulin G-binding ligands with platelets and platelet-associated immunoglobulin G. (1984) (47)
Measurement of the third component of complement bound to red blood cells in patients with the cold agglutinin syndrome. (1973) (47)
Factors controlling erythropoiesis in birds. (1966) (46)
Pseudo-Bernard-Soulier syndrome: thrombocytopenia caused by autoantibody to platelet glycoprotein Ib. (1987) (46)
The PIG-A Mutation and Absence of Glycosylphosphatidylinositol-Linked Proteins Do Not Confer Resistance to Apoptosis in Paroxysmal Nocturnal Hemoglobinuria (1998) (45)
Paroxysmal nocturnal hemoglobinuria and the glycosylphosphatidylinositol anchor. (1994) (45)
THE ERYTHROPOIESIS‐STIMULATING FACTORS PRODUCED BY TUMORS (1968) (45)
Quantitative immunology of immune hemolytic anemia. I. The fixation of C1 by autoimmune antibody and heterologous anti-IgG antibody. (1971) (42)
Red‐Cell Abnormalities in HEMPAS (Hereditary Erythroblastic Multinuclearity with a Positive Acidified‐Serum Test) (1972) (42)
Structure-function relationships of the complement regulatory protein, CD59. (1996) (39)
Two populations of granulocytes in paroxysmal nocturnal hemoglobinuria. (1979) (37)
Paroxysmal nocturnal hemoglobinuria. Alternate-complement-pathway-mediated lysis induced by magnesium. (1973) (36)
The role of the kidney in the erythropoietic response to hypoxia in parabiotic rats. (1962) (34)
Glycosyl-phosphatidylinositol anchor synthesis in paroxysmal nocturnal hemoglobinuria: partial or complete defect in an early step. (1994) (34)
Identification of platelet proteins that bind alloantibodies and autoantibodies. (1984) (33)
Intravenous immunoglobulin administration in the treatment of severe chronic immune thrombocytopenic purpura. (1984) (33)
A COMPARISON OF SOME PHYSICAL AND CHEMICAL PROPERTIES OF ERYTHROPOIESIS-STIMULATING FACTORS FROM DIFFERENT SOURCES. (1964) (32)
Some molecular characteristics of erythropoietin from different sources determined by inactivation ionizing radiation. (1963) (32)
The Pelger-Huët anomaly in three families and its use in determining the disappearance of transfused neutrophils from the peripheral blood. (1959) (32)
Distinct restriction of complement- and cell-mediated lysis. (1989) (32)
Immunologic mechanisms in autoimmune hemolytic disease. (1976) (32)
Comparison of the efficacy of a two-day and a five-day schedule for infusing intravenous gamma globulin in the treatment of immune thrombocytopenic purpura in adults. (1987) (31)
Differences in the terminal steps of complement lysis of normal and paroxysmal nocturnal hemoglobinuria red cells. (1978) (31)
Reaction of cold agglutinins with I antigen solubilized from human red cells. (1970) (31)
The use of radiolabeled and fluorescein-labeled antiglobulins in assays to predict platelet transfusion outcome. (1984) (30)
Evolution of clinical understanding: Paroxysmal nocturnal hemoglobinuria as a paradigm (1993) (30)
Cold agglutinin autoimmune hemolytic anemia in nonhematologic malignancies (1979) (30)
Further evidence for location of the spherocytosis gene on chromosome 8. (1983) (29)
Treatment of paroxysmal nocturnal hemoglobinuria. (1982) (29)
Transfusion Support for Patients With Sickle Cell Disease (1998) (29)
Hemoglobin S/OARAB: Thirteen new cases and review of the literature (1999) (29)
THE METABOLISM OF ERYTHROPOIETIN IN PATIENTS WITH ANEMIA DUE TO DEFICIENT ERYTHROPOIESIS. (1964) (29)
The Lysis of Paroxysmal Nocturnal Haemoglobinuria Red Cells by Serum and Cobra Factor (1972) (27)
Efficient retrovirus-mediated PIG-A gene transfer and stable restoration of GPI-anchored protein expression in cells with the PNH phenotype. (2001) (27)
Refocusing on history-taking skills during internal medicine training. (1996) (27)
Separation of the acetylcholinesterase-deficient red cells in paroxysmal nocturnal hemoglobinuria. (1986) (26)
Chlorpropamide-induced immune hemolytic anemia. (1970) (25)
Genetic instability and the etiology of somatic PIG-A mutations in paroxysmal nocturnal hemoglobinuria. (1999) (25)
Pulmonary embolism and splenic infarction in a patient with sickle cell trait (1990) (23)
Structural characteristics of hemolytic antibodies as determined by the effects of ionizing radiation. (1967) (22)
The control of complement activation by the blood cells in paroxysmal nocturnal hemoglobinuria. (1986) (22)
Paroxysmal nocturnal hemoglobinuria--present status and future prospects. (1980) (22)
Paroxysmal nocturnal haemoglobinuria. (1985) (22)
The acetylcholinesterase defect in paroxysmal nocturnal hemoglobinuria: evidence that the enzyme is absent from the cell membrane. (1985) (21)
Hemolysis by complement and cold‐reacting antibodies: Time and temperature requirements (1977) (21)
Paroxysmal nocturnal hemoglobinuria: molecular pathogenesis and molecular therapeutic approaches. (1998) (21)
Paroxysmal cold hemoglobinuria associated with non-Hodgkin's lymphoma. (1994) (20)
Congential dyserythropoietic anemia--type IV. (1975) (19)
Recurrent thrombocytopenia following idiopathic thrombocytopenic purpura. The importance of platelet-bound IgG in establishing cause. (1980) (18)
Erythropoietin Assays Using Iron59 Incorporation into Blood and Spleen of the Polycythemic Mouse (1962) (18)
Cold-reacting antibodies: the enhancement of antibody fixation by the first component of complement (C'1a). (1968) (17)
Endogenous carbon monoxide production measured by gas-phase analysis: an estimation of heme catabolic rate. (1971) (17)
Factors stimulating erythropoiesis in frogs. (1963) (17)
Protrusio acetabuli in sickle-cell anemia. (1983) (17)
Lea blood group antigen on human platelets. (1985) (17)
The PIG-A mutation and absence of glycosylphosphatidylinositol-linked proteins do not confer resistance to apoptosis in paroxysmal nocturnal hemoglobinuria. (1998) (17)
Epidemiology of PNH (1996) (17)
The presence of the Ii blood group system on human platelets. (1984) (16)
The reactivity of red blood cell membrane glycophorin with "cold-reacting" antibodies. (1975) (15)
The glycolipid anchor of membrane surface proteins. (1993) (15)
Complement-dependent immune adherence measured with human granulocytes: changes in the antigenic nature of red cell-bound C3 produced by incubation in human serum. (1973) (15)
Clinical immunohematology : basic concepts and clinical applications (1990) (14)
Transfusion in paroxysmal nocturnal hemoglobinuria (1989) (14)
Whatever happened to vinca-loaded platelets? (1984) (14)
Paroxysmal nocturnal haemoglobinuria in aplastic anaemia. (1978) (14)
Clinical benefit of eculizumab in patients with no transfusion history in the International Paroxysmal Nocturnal Haemoglobinuria Registry (2017) (14)
Hemoglobin S/O(Arab): thirteen new cases and review of the literature. (1999) (14)
The effect of synthetic androgens in hereditary angioneurotic edema: alteration of C1 inhibitor and C4 levels. (1976) (13)
Presence of P blood group antigens on human platelets. (1985) (13)
Successful treatment of hepatitis C in sickle-cell disease. (2000) (13)
The hematopoietic defect in PNH is not due to defective stroma, but is due to defective progenitor cells. (2002) (12)
Autoimmune hemolytic anemia. (1985) (12)
Selective chemotherapy of macrophages in the treatment of idiopathic thrombocytopenic purpura. (1978) (12)
Intrathoracic extramedullary hematopoiesis: a scan diagnosis. (1968) (11)
Prognostic Implications for Direct Platelet‐Associated IgG in Childhood Idiopathic Thrombocytopenic Purpura (1986) (11)
A Brief History of PNH (2000) (10)
The autinglobulin test in autoimmune hemolytic anemia. (1975) (10)
Posttransfusion purpura. Report of a case with anti-P1A1 masked by HLA antibodies. (1985) (10)
Hemolytic Transfusion Reactions Caused by Failure of Commercial Antiglobulin Reagents To Detect Complement (2003) (9)
Platelet antibody in prolonged remission of childhood idiopathic thrombocytopenic purpura. (1985) (9)
Paroxysmal nocturnal hemoglobinuria and decay-accelerating factor. (1990) (8)
Evaluation of Paroxysmal Nocturnal Hemoglobinuria Disease Burden: The Patient's Perspective. A Report From the International PNH Registry. (2010) (8)
"Early-peak" carbon monoxide production in certain erythropoietic disorders. (1975) (8)
Structural and functional differences between decay-accelerating factor and red cell acetylcholinesterase. (1986) (8)
Correlation of in vivo and in vitro measurements of hemolysis in hemolytic anemia due to immune ractions. (1973) (8)
Quantitative evaluation of antibody‐dependent lymphocyte‐mediated lysis of human red cells (1979) (7)
The detection of small amounts of antibody on the red cell in autoimmune hemolytic anemia. (1974) (7)
Glycosyl-phosphatidylinositol anchor synthesis in paroxysmal nocturnal hemoglobinuria: partial or complete defect in an early step (1994) (6)
Treatment of chronic immune thrombocytopenia. (1983) (6)
Diagnosis and treatment of the painful episode in sickle cell disease. (1983) (5)
Thrombophilic DNA Mutations As Independent Risk Factors for Stroke and Avascular Necrosis in Sickle Cell Anemia (2001) (5)
The role of complement in the sensitivity of the paroxysmal nocturnal haemoglobinuria red cell to immune lysis. (1965) (5)
Erratum: “Long‐term effect of the complement inhibitor eculizumab on kidney function in patients with paroxysmal nocturnal hemoglobinura” by Hillmen et al., Am J Hematol 553–559, 2010, DOI number 21757 (2010) (4)
Does maternal platelet-associated or platelet-bindable IgG correlate with levels in umbilical cord blood or colostrum during normal pregnancy? (1988) (4)
Absence of phosphatidylinositol (PI)‐linked proteins in a very early human multipotential haematopoietic marrow cell (1991) (4)
Hematopoiesis and the defect in paroxysmal nocturnal hemoglobinuria. (1997) (4)
Studies on erythropoiesis. X. The use of bone marrow tissue culture in demonstrating erythropoietin. (1959) (4)
Eculizumab Protects Against TE and Prolongs Survival in Patients with Paroxysmal Nocturnal Hemoglobinuria: An International PNH Registry Study (2012) (3)
Measurement of the Third Component of Complement (1973) (3)
Philip Levine Award lecture. The lysis of erythrocytes by incomplete antibodies. (1982) (3)
Splenectomy in sickle-cell disease. (1979) (3)
Effects of immune reactions on the red cell membrane. (1970) (3)
Clinical management of adult ITP prior to splenectomy: a perspective. (2002) (3)
[Hypoproliferative disorders of stem cells]. (1997) (2)
Interactions of complement with the red-cell membrane. (1979) (2)
Use of Blood Transfusions In Paroxysmal Nocturnal Hemoglobinuria Patients with and without Aplastic Anemia Enrolled In the Global PNH Registry (2010) (2)
Clinical characteristics of classic Paroxysmal Nocturnal Hemoglobinuria (PNH) in pediatric patients: a comparison with classic PNH in adults. An international PNH registry study (2011) (2)
Immunologic studies before and after splenectomy in a patient with the Wiskott-Aldrich syndrome (2004) (2)
Status of the MNSs antigens on human platelets (1987) (2)
A new way to prevent thrombosis (2007) (2)
The complement sensitivity on PNH cells. (1972) (2)
Clinical Benefit of Eculizumab in Patients with No Transfusion History in the International Paroxysmal Nocturnal Hemoglobinuria Registry (2015) (1)
Serum potassium concentration and use of ouabain in experimental tourniquet shock. (1957) (1)
Serial Analysis of Clonal Expansion in PNH by Flow Cytometry (2003) (1)
Paroxysmal Nocturnal Hemoglobinuria and Complement (1998) (1)
Acute Myeloblastic Leukemia in Paroxysmal Nocturnal Hemoglobinuria Evidence of Evolution from the Abnormal Paroxysmal Nocturnal Hemoglobinuna Clone (2013) (1)
Review in translational hematology Diagnosis and management of paroxysmal nocturnal hemoglobinuria (2005) (1)
PLATELET FACTOR H REGULATES THE ACTIVITY OF THE ALTERNATIVE PATHWAY OF COMPLEMENT ON THE SURFACE OF NORMAL AND PAROXYSMAL NOCTURNAL HEMOGLOBINURIA PLATELETS (1987) (1)
A Short History of Paroxysmal Nocturnal Hemoglobinuria: How We Came To Understand Its Natural History (2003) (1)
Paroxysmal Nocturnal Hemoglobinuria: New Thoughts (1970) (1)
Complement and the Paroxysmal Nocturnal Haemoglobinuria Red Cell (2008) (1)
804 PLATELET ASSOCIATED IMMUNOGLOBULIN, PLATELET SIZE AND THE EFFECT OF SPLENECTOMY IN THE WISKOTT-ALDRICH SYNDROME (1981) (1)
The structure and function of CD59: The importance of the disulfide structure and identification of a primary epitope (1993) (1)
Results of a Survey of the Prevalence of Paroxysmal Nocturnal Hemoglobinuria (PNH). (2004) (1)
How many mutations does it take to get PNH (2006) (1)
The mechanisms of destruction of antibody-altered cells. (1982) (0)
The Biochemistry of the Antigens of the Red Blood Cell Membrane (2020) (0)
The Clinical Course of PNH in the USA and in JAPAN (2003) (0)
ERYTHROPOIESIS-STIMULATING AGENT ( ESA ) TREATMENT OF MDS : CONTROVERSIES AND PERSPECTIVES (0)
Polycythemia in rats with adrenal cortical carcinoma transplants. (1966) (0)
way to prevent thrombosis? Novel player in cell recruitment (2007) (0)
THE FIXATION OF C 1 BY AUTOIMMUNE ANTIBODY AND HETEROLOGOUS ANTI-IGG ANTIBODY (0)
Book Review Hematology: Basic principles and practice Edited by Ronald Hoffman, EdwardJ. Benz,Jr., SanfordJ. Shattil, Bruce Furie, and Harvey J. Cohen. 1919 pp., illustrated. New York, Churchill Livingstone, 1991. $110. (1991) (0)
Clinical immunology update : reviews for physicians : 1985 edition (1985) (0)
A History of Research of PNH: Defining a Disease (2017) (0)
Posttransfusion purpura (2009) (0)
autoantibody to platelet glycoprotein Ib Pseudo-Bernard-Soulier syndrome: thrombocytopenia caused by (2011) (0)
New views of sickle cell disease. (1997) (0)
A Global Registry of Patients with Paroxysmal Nocturnal Hemoglobinuria. (2009) (0)
The membrane abnormalities in paroxysmal nocturnal hemoglobinuria (PNH). (1979) (0)
Mechanisms of Increased Susceptibility to C Lysis of Abnormal Human Red Blood Cells (1973) (0)
Book reviews (2004) (0)
Immunology Of The Platelet Surface (1981) (0)
Potassium Permeability in f-Thalassemia Minor Red Blood Cells (0)
Diagnostic approach to hemolytic anemias. (1971) (0)
Book ReviewHemolytic Anemia in Disorders of Red Cell Metabolism (1979) (0)

This paper list is powered by the following services:

What Schools Are Affiliated With Wendell F. Rosse?

Wendell F. Rosse is affiliated with the following schools:

Duke University

Wendell F. Rosse's Academic­Influence.com Rankings

Why Is Wendell F. Rosse Influential?

Wendell F. Rosse's Published Works

Published Works

What Schools Are Affiliated With Wendell F. Rosse?

Wendell F. Rosse's AcademicInfluence.com Rankings